Document is current
Any future updates will be listed below
-
Authors
Wei, Wanting
Kuroda, Makoto
Liu, Yanan
Iida, Shun https://orcid.org/0000-0003-2258-9031
Kandel, Sangam https://orcid.org/0000-0002-2875-6462
Machovech, Heather
Hirata, Yuichiro https://orcid.org/0009-0009-2503-1077
Suzuki, Tadaki https://orcid.org/0000-0002-3820-9542
Koelle, Katia https://orcid.org/0000-0002-0254-6141
Wang, Zhongde https://orcid.org/0000-0003-2441-4729
Friedrich, Thomas C. https://orcid.org/0000-0001-9831-6895
Kawaoka, Yoshihiro https://orcid.org/0000-0001-5061-8296
Halfmann, Peter J. https://orcid.org/0000-0002-1648-1625
-
Funding
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (R21AI164001)
Japan Agency for Medical Research and Development (JP24wm0125008)
Japan Agency for Medical Research and Development (JP24fk0108637)
Japan Agency for Medical Research and Development (JP25fk0108732)
Japan Agency for Medical Research and Development (JP223fa627003)
Japan Agency for Medical Research and Development (JP243fa727002)
- License Information
-
More Information
Article History
Received: 20 June 2025
Accepted: 19 December 2025
First Online: 8 January 2026
Competing interests
: Y.K. has received unrelated funding support from Daiichi Sankyo Pharmaceutical, Toyama Chemical, Tauns Laboratories, Inc., Shionogi & Co. Ltd, Otsuka Pharmaceutical, KM Biologics, Kyoritsu Seiyaku, Shinya Corporation, and Fuji Rebio. The other authors declare that they have no competing interests.
